Literature DB >> 25051433

Early-onset type 2 diabetes impairs skeletal acquisition in the male TALLYHO/JngJ mouse.

M J Devlin1, M Van Vliet, K Motyl, L Karim, D J Brooks, L Louis, C Conlon, C J Rosen, M L Bouxsein.   

Abstract

Type 2 diabetes (T2D) incidence in adolescents is rising and may interfere with peak bone mass acquisition. We tested the effects of early-onset T2D on bone mass, microarchitecture, and strength in the TALLYHO/JngJ mouse, which develops T2D by 8 weeks of age. We assessed metabolism and skeletal acquisition in male TALLYHO/JngJ and SWR/J controls (n = 8-10/group) from 4 weeks to 8 and 17 weeks of age. Tallyho mice were obese; had an approximately 2-fold higher leptin and percentage body fat; and had lower bone mineral density vs SWR at all time points (P < .03 for all). Tallyho had severe deficits in distal femur trabecular bone volume fraction (-54%), trabecular number (-27%), and connectivity density (-82%) (P < .01 for all). Bone formation was higher in Tallyho mice at 8 weeks but lower by 17 weeks of age vs SWR despite similar numbers of osteoblasts. Bone marrow adiposity was 7- to 50-fold higher in Tallyho vs SWR. In vitro, primary bone marrow stromal cell differentiation into osteoblast and adipocyte lineages was similar in SWR and Tallyho, suggesting skeletal deficits were not due to intrinsic defects in Tallyho bone-forming cells. These data suggest the Tallyho mouse might be a useful model to study the skeletal effects of adolescent T2D.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25051433      PMCID: PMC4164927          DOI: 10.1210/en.2014-1041

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  52 in total

Review 1.  The global spread of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

Review 2.  The genetic landscape of type 2 diabetes in mice.

Authors:  Susanne M Clee; Alan D Attie
Journal:  Endocr Rev       Date:  2006-10-03       Impact factor: 19.871

3.  Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.

Authors:  Xiang-Hang Luo; Li-Juan Guo; Hui Xie; Ling-Qing Yuan; Xian-Ping Wu; Hou-De Zhou; Er-Yuan Liao
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

4.  Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

Authors:  Sergiu Botolin; Marie-Claude Faugere; Hartmut Malluche; Michael Orth; Ron Meyer; Laura R McCabe
Journal:  Endocrinology       Date:  2005-05-19       Impact factor: 4.736

5.  Serum adiponectin and bone mineral density in women.

Authors:  J B Richards; A M Valdes; K Burling; U C Perks; T D Spector
Journal:  J Clin Endocrinol Metab       Date:  2007-01-30       Impact factor: 5.958

6.  Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice.

Authors:  Jung Han Kim; Taryn P Stewart; Morvarid Soltani-Bejnood; Luan Wang; Jennifer M Fortuna; Ola A Mostafa; Naima Moustaid-Moussa; Ahmed M Shoieb; Michael F McEntee; Yun Wang; Lawrence Bechtel; Jürgen K Naggert
Journal:  J Endocrinol       Date:  2006-11       Impact factor: 4.286

7.  Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways.

Authors:  Sergiu Botolin; Laura R McCabe
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

8.  Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.

Authors:  Vaida Glatt; Ernesto Canalis; Lisa Stadmeyer; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2007-08       Impact factor: 6.741

Review 9.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

10.  Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables.

Authors:  Jaak Jürimäe; Toivo Jürimäe
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-06       Impact factor: 4.310

View more
  37 in total

1.  Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.

Authors:  Lamya Karim; Julia Moulton; Miranda Van Vliet; Kelsey Velie; Ann Robbins; Fatemeh Malekipour; Ayesha Abdeen; Douglas Ayres; Mary L Bouxsein
Journal:  Bone       Date:  2018-05-30       Impact factor: 4.398

2.  Marrow adipose tissue composition in adults with morbid obesity.

Authors:  Elaine W Yu; Logan Greenblatt; Alireza Eajazi; Martin Torriani; Miriam A Bredella
Journal:  Bone       Date:  2016-12-30       Impact factor: 4.398

3.  Methodological considerations when studying the skeletal response to glucose intolerance using the diet-induced obesity model.

Authors:  Elizabeth Rendina-Ruedy; Brenda J Smith
Journal:  Bonekey Rep       Date:  2016-10-26

Review 4.  The emerging role of bone marrow adipose tissue in bone health and dysfunction.

Authors:  Thomas H Ambrosi; Tim J Schulz
Journal:  J Mol Med (Berl)       Date:  2017-11-03       Impact factor: 4.599

5.  Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age.

Authors:  Amy Creecy; Sasidhar Uppuganti; Mustafa Unal; R Clay Bunn; Paul Voziyan; Jeffry S Nyman
Journal:  Bone       Date:  2018-02-10       Impact factor: 4.398

6.  Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus.

Authors:  Y J Choi; S Y Ock; Y Jin; J S Lee; S H Kim; Y -S Chung
Journal:  Osteoporos Int       Date:  2018-01-10       Impact factor: 4.507

7.  High dietary fat and sucrose results in an extensive and time-dependent deterioration in health of multiple physiological systems in mice.

Authors:  James G Burchfield; Melkam A Kebede; Christopher C Meoli; Jacqueline Stöckli; P Tess Whitworth; Amanda L Wright; Nolan J Hoffman; Annabel Y Minard; Xiuquan Ma; James R Krycer; Marin E Nelson; Shi-Xiong Tan; Belinda Yau; Kristen C Thomas; Natalie K Y Wee; Ee-Cheng Khor; Ronaldo F Enriquez; Bryce Vissel; Trevor J Biden; Paul A Baldock; Kyle L Hoehn; James Cantley; Gregory J Cooney; David E James; Daniel J Fazakerley
Journal:  J Biol Chem       Date:  2018-02-13       Impact factor: 5.157

8.  The effects of Exendin-4 on bone marrow-derived mesenchymal cells.

Authors:  Paola Luciani; Benedetta Fibbi; Benedetta Mazzanti; Cristiana Deledda; Lara Ballerini; Alessandra Aldinucci; Susanna Benvenuti; Riccardo Saccardi; Alessandro Peri
Journal:  Endocrine       Date:  2017-11-01       Impact factor: 3.633

Review 9.  Clinical implications of bone marrow adiposity.

Authors:  A G Veldhuis-Vlug; C J Rosen
Journal:  J Intern Med       Date:  2018-01-15       Impact factor: 8.989

Review 10.  Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.

Authors:  Lamya Karim; Mary L Bouxsein
Journal:  Bone       Date:  2015-07-23       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.